{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04720599",
      "OrgStudyIdInfo": {
        "OrgStudyId": "ECT2020-002"
      },
      "Organization": {
        "OrgFullName": "Exosome Diagnostics, Inc.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy",
      "OfficialTitle": "Clinical Evaluation of ExoDx™ Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy"
    },
    "StatusModule": {
      "StatusVerifiedDate": "December 2020",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "June 1, 2020",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 1, 2021",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "June 1, 2021",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "January 20, 2021",
      "StudyFirstSubmitQCDate": "January 20, 2021",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 22, 2021",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "September 29, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 30, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Exosome Diagnostics, Inc.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The study described here is being conducted to prospectively confirm the performance of the ExoDx Prostate gene expression assay in patients presenting for an initial prostate biopsy and support of CE-marking the test for a European Union Launch."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Urologic Cancer"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "exosome",
          "ExoDx Prostate"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Observational",
      "PatientRegistry": "No",
      "DesignInfo": {
        "DesignObservationalModelList": {
          "DesignObservationalModel": [
            "Cohort"
          ]
        },
        "DesignTimePerspectiveList": {
          "DesignTimePerspective": [
            "Prospective"
          ]
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "120",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Diagnostic Test",
            "InterventionName": "ExoDx Prostate(IntelliScore)",
            "InterventionDescription": "The ExoDx Prostate test result supports the biopsy decision process by stratifying patients based on risk for high grade prostate cancer",
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "EPI",
                "EPI-CE"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Correlation of the ExoDx Prostate test results with the outcome of prostate biopsies in an initial biopsy patient cohort.",
            "PrimaryOutcomeTimeFrame": "1 year"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nClinical suspicion for prostate cancer\nElevated Prostate-specific Antigen between 2.0-10 ng/ mL\nScheduled for a initial prostate biopsy\n\nExclusion Criteria:\n\nClinical symptoms of urinary tract infection (including prostatitis) at the time of enrollment.\nHistory of prostate cancer.\nHistory of invasive treatments for benign prostatic hypertrophy (BPH) or lower urinary track symptoms within 6 months of study enrollment.\nKnown hepatitis status (all types) and/or HIV documented in patient's medical record.\nPatients with history of concurrent renal/bladder tumors.\nPrior MRI used in the decision to biopsy",
      "Gender": "Male",
      "GenderBased": "Yes",
      "GenderDescription": "Participants with prostates",
      "MinimumAge": "50 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      },
      "StudyPopulation": "- Men, aged 50yrs or older with an elevated PSA between 2-10ng/ml scheduled for an initial biopsy",
      "SamplingMethod": "Non-Probability Sample"
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Mikkel Noerholm",
            "OverallOfficialAffiliation": "Exosome Diagnostics, Inc.",
            "OverallOfficialRole": "Study Director"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Chesapeake Urology Research Associates",
            "LocationCity": "Baltimore",
            "LocationState": "Maryland",
            "LocationZip": "21204",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "New Jersey Urology",
            "LocationCity": "Voorhees",
            "LocationState": "New Jersey",
            "LocationZip": "08043",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Klinikum der Universität München",
            "LocationCity": "München",
            "LocationCountry": "Germany"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Yes",
      "IPDSharingDescription": "IPD can be shared on an individual basis. Please reach out for more information.",
      "IPDSharingInfoTypeList": {
        "IPDSharingInfoType": [
          "Study Protocol",
          "Informed Consent Form (ICF)"
        ]
      },
      "IPDSharingTimeFrame": "12 months after trial completion",
      "IPDSharingAccessCriteria": "Individual basis upon mutual agreement"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000014571",
            "ConditionMeshTerm": "Urologic Neoplasms"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000014565",
            "ConditionAncestorTerm": "Urogenital Neoplasms"
          },
          {
            "ConditionAncestorId": "D000009371",
            "ConditionAncestorTerm": "Neoplasms by Site"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M16472",
            "ConditionBrowseLeafName": "Urologic Neoplasms",
            "ConditionBrowseLeafAsFound": "Urologic Cancer",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M16467",
            "ConditionBrowseLeafName": "Urogenital Neoplasms",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}